Besides HIF-1α silencing is sufficient to completely lose Multidrug Resistance 1 gene (MDR1) expression (the gene that guides the Multi-Drug Resistance, a critical challenge in BC) and to restore the chemo-sensitivity in tumour cells [26, 27]. This evidence concerns the gene HIF1A and breast cancer.